Dergiler / Neurological sciences and neurophysiology (Online) / 2019 / Cilt: 36 - Sayı: 1

Relationship between diaphragm MEP and swallowing, respiratory function and survive in ALS patients

Sayfa
38–43
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In ALS patients, the disappearance of Dia-Cx-MEP in spite of the Dia-Sp-MEP can reflect the deterioration of the respiratory pathway from motor cortex.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To investigate the relationship between diaphragm motor evoked potential (Dia-MEP) with swallowing, respiratory function and survive in amyotrophic lateral sclerosis (ALS) patients.
📊
Temel Bulgular & Veri:Methods: Twenty-three ALS patients and 15 healthy subjects were included in the study.
💡
Sonuç & Katkı:In ALS patients, the disappearance of Dia-Cx-MEP in spite of the Dia-Sp-MEP can reflect the deterioration of the respiratory pathway from motor cortex.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: To investigate the relationship between diaphragm motor evoked potential (Dia-MEP) with swallowing, respiratory function and survive in amyotrophic lateral sclerosis (ALS) patients. Methods: Twenty-three ALS patients and 15 healthy subjects were included in the study. Pulmonary function tests were per-formed using forced vital capacity and maximal sniff nasal pressure. Swallowing functions of patients were examined using the dysphagia limit. Transcranial magnetic stimulation (TMS) was applied in ALS patients and healthy subjects. Bilateral cortical and spinal motor evoked potential (MEP) of hemidiaphragm and abductor pollicis brevis (APB) muscles were recorded. Latencies and amplitudes of cortical and spinal MEPs and central motor conduction time (CMCT) were measured. Results: In the ALS group, obtaining rates of cortical MEP from APB and diaphragm muscles were statistically significantly lower than the healthy group. Obtaining rates of cortical diaphragm MEP (Dia-Cx-MEP) were lower in patients with dysphagia and respiratory dysfunction and patients who died but the difference was statistically significant for only patients with respiratory dysfunction. There were no significant difference between amplitudes and latencies of Dia-Cx-MEPl and spinal diaphragm MEP (Dia-Sp-MEP) in patients with and without dysphagia or respiratory dysfunction and patients who died or survived. Conclusion: There were no significant correlations between the Dia-Cx-MEP and Dia-Sp-MEP latency values and the CMCT values of Dia-MEP and the respiratory measures. In ALS patients, the disappearance of Dia-Cx-MEP in spite of the Dia-Sp-MEP can reflect the deterioration of the respiratory pathway from motor cortex.

🔖

Bu Makaleye Atıf Yap

ERDEM, N. Ş., USLU, F. İ., BOZKURT, S., UYSAL, H. (2019). Relationship between diaphragm MEP and swallowing, respiratory function and survive in ALS patients. Neurological sciences and neurophysiology (Online), Cilt: 36 - Sayı: 1, 38–43. https://ajindex.com/articles/286136

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclero-sis. Lancet Neurol 2015
  2. [CrossRef] 2. Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Ep-idemiology of amyotrophic lateral sclerosis: A review of litera-ture. Rev Neurol (Paris) 2016
  3. [CrossRef] 3. Prell T, Ringer TM, Wullenkord K, et al. Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?J Neurol Neurosurg Psychiatry 2016
  4. [CrossRef] 4. Paris G, Martinaud O, Petit A, et al. Oropharyngeal dysphagia in amyotrophic lateral sclerosis alters quality of life. J Oral Rehabil 2013
  5. [CrossRef] 5. Kaufmann P, Levy G, Thompson JL, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005
  6. [CrossRef] 6. Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS-progres-sion. J Neurol Sci 2008
  7. [CrossRef] 7. Velasco R, Salachas F, Munerati E, et al. Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival. Rev Neurol (Paris) 2002
  8. Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: patho-physiological insights. J Neurol Neurosurg Psychiatry 2013
  9. [CrossRef] 9. Menon P, Geevasinga N, Yiannikas C, Howells J, Kiernan MC, Vucic S. Sensitivity and specificity of threshold tracking transcranial mag-netic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study. Lancet Neurol 2015
  10. [CrossRef] 10. Floyd AG, Yu QP, Piboolnurak P, et al. Transcranial magnetic stim-ulation in ALS: utility of central motor conduction tests. Neurol-ogy 2009
  11. [CrossRef] 11. Miscio G, Pisano F, Mora G, Mazzini L. Motor neuron disease: use-fulness of transcranial magnetic stimulation in improving the di-agnosis. Clin Neurophysiol 1999
  12. [CrossRef] 12. Schulte-Mattler WJ, Müller T, Zierz S. Transcranial magnetic stim-ulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci 1999
  13. [CrossRef] 13. Kaufmann P, Pullman S, Shungu DC, et al. Objective tests for up-per motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004
  14. [CrossRef] 14. Vucic S, Cheah BC, Yiannikas C, Kiernan M